Form 4: Hippo Holdings Executive Sells Shares Under 10b5-1 Plan

Michael Stienstra, a General Manager and Chief Insurance Officer at Hippo Holdings, sold 855 shares of common stock at $25.55 per share on November 8, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Michael Stienstra, a General Manager and Chief Insurance Officer at Hippo Holdings, sold 855 shares of common stock.
• The sale occurred on November 8, 2024, at a price of $25.55 per share.
• The transaction was executed under a pre-arranged Rule 10b5-1 trading plan established on March 21, 2024.
• Following the transaction, Stienstra beneficially owns 70,249 shares, which includes 51,867 Restricted Stock Units (RSUs).

Sentiment

Score: 5

Explanation: The document is a routine disclosure of an insider stock sale under a pre-arranged plan, which is neither positive nor negative for the company's overall prospects.

Industry Context

This is a routine disclosure of an insider stock sale, which is common for executives of publicly traded companies. The use of a 10b5-1 plan indicates the sale was pre-planned and not based on any material non-public information.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan is a standard practice for executives at publicly traded companies like Hippo Holdings to avoid accusations of insider trading.
• Similar filings are regularly made by executives at comparable companies such as Lemonade (LMND) and Root (ROOT) when they sell shares.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on shareholder sentiment, but the pre-planned nature of the sale mitigates any significant concerns.

Key Dates

Keywords

Hippo Holdings, insider trading, Form 4, 10b5-1 plan, stock sale, executive, Michael Stienstra, HIPO